| RS1574001405 |
SNRNP200
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1574003784 |
CHRNA1
|
Health Risk |
Likely pathogenic |
— |
| RS1574004452 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574005235 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1574005451 |
REEP1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS1574005699 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574006637 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Severe myoclonic epilepsy in infancy |
| RS1574006857 |
SCN1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy 6B |
| RS1574007140 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1574007436 |
CHRNA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome, Lethal multiple pterygium syndrome |
| RS1574011727 |
CHRNA1
|
Health Risk |
Likely pathogenic |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS1574014358 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1574016452 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1574039742 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574042462 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy |
| RS1574047005 |
CNNM4
|
Health Risk |
Likely pathogenic |
Jalili syndrome, Jalili syndrome |
| RS1574047454 |
CNNM4
|
Health Risk |
Likely pathogenic |
Jalili syndrome, Jalili syndrome |
| RS1574050861 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1574051096 |
GFPT1
|
Health Risk |
Likely pathogenic |
— |
| RS1574051206 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1574051496 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574051665 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574052179 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574052546 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Generalized epilepsy with febrile seizures plus |
| RS1574058076 |
GFPT1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 12, Congenital myasthenic syndrome 12 |
| RS1574060250 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574060717 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574060743 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1574061044 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574066113 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS1574066341 |
GFPT1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 12, Congenital myasthenic syndrome 12 |
| RS1574066599 |
GFPT1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 12, Congenital myasthenic syndrome 12 |
| RS1574068971 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Generalized epilepsy with febrile seizures plus |
| RS1574069096 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1574069132 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574070639 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1574070787 |
TTC21B
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS1574077466 |
CERKL
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS1574077569 |
REEP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 31, Spastic paraplegia |
| RS1574081963 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1574083547 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary familial dilated cardiomyopathy, Cardiovascular phenotype |
| RS1574084195 |
PDE11A
|
Health Risk |
Likely pathogenic |
Pigmented nodular adrenocortical disease, primary |
| RS1574087037 |
TTN
|
Health Risk |
Likely pathogenic |
Primary familial dilated cardiomyopathy, Cardiovascular phenotype |
| RS1574097294 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS1574099951 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1574100501 |
RAB3GAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS1574121486 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS1574132879 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS1574152522 |
TBR1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autism and speech delay, Intellectual developmental disorder with autism and speech delay |
| RS1574152672 |
TBR1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and speech delay, Intellectual developmental disorder with autism and speech delay |
| RS1574159505 |
SCN3A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS1574166948 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1574168611 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574169179 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574170908 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574172286 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1574182550 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574183148 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS1574192005 |
SCN1A
|
Health Risk |
Pathogenic |
Seizure, Early-infantile DEE |
| RS1574192998 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574197 |
DHFR;MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS1574201555 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574201591 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574202324 |
SCN1A
|
Health Risk |
Pathogenic |
SCN1A-related disorder, Severe myoclonic epilepsy in infancy |
| RS1574208760 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574209023 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1574212904 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1574214734 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS1574216450 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1574217232 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574223964 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1574224274 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574225593 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574226259 |
CALCRL
|
Health Risk |
Pathogenic |
Lymphatic malformation 8, Lymphatic malformation 8 |
| RS1574234690 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Generalized epilepsy with febrile seizures plus |
| RS1574240716 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574263047 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574263819 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574264671 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1574264920 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1574265144 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1574265485 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1574266171 |
KCNH1
|
Health Risk |
Likely pathogenic |
— |
| RS1574266328 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1574266490 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1574266816 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, SCN1A Seizure Disorders |
| RS1574270768 |
SCN3A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS1574271602 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574271644 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574271827 |
SCN1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1574272192 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574277160 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1574281711 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Severe myoclonic epilepsy in infancy |
| RS1574282312 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1574291210 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574302195 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1574303761 |
DCAF17
|
Health Risk |
Pathogenic |
Woodhouse-Sakati syndrome, Woodhouse-Sakati syndrome |
| RS1574312497 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1574315873 |
MECR
|
Health Risk |
Pathogenic |
Dystonia, childhood-onset |
| RS1574322133 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |